# Aptamer Group signs agreement worth up to £155,000

- Link: https://www.directorstalkinterviews.com/aptamer-group-signs-agreement-worth-up-to-155000/4121181607
- Published: 2024-12-19T07:52:05+00:00
- Author: Amilia Stone

**Aptamer Group plc** (LON: APTA), the developer of novel Optimer^(®) binders to
enable innovation in the life sciences industry, has announced the signing of a 
new development contract with a rare disease biopharmaceutical company. The agreement,
worth up to £155,000, focuses on developing two Optimer binders as critical reagents
for therapeutic monitoring. Upon successful development, Aptamer could receive a
significant undisclosed IP transfer fee for the use of the Optimers in clinical 
trial monitoring.

> **Dr Arron Tolley, Chief Executive Officer of Aptamer Group, commented: **“This
> agreement further demonstrates our strategic model of leveraging fee-for-service
> revenue for the development of Optimer binders and potential licensing revenues.
> With a healthy pipeline and increasing traction among both new and repeat customers,
> we are demonstrating our commercial strategy. These advancements align with our
> broader vision of driving shareholder value by pairing fee-for-service income 
> with scalable licensing opportunities. We remain focused on delivering on our 
> growth objectives and look forward to sharing updates on our continued progress.”

Share on: